Bispecific Antibodies Poised for $60B Market by 2031 as 550+ Trials Reshape Therapeutics
Bispecific antibody market projected to reach $60 billion by 2031 from $16 billion in 2025, with 550+ clinical trials and 18 approved drugs driving sector transformation.
AMGNJNJPFEABBVRHHBY+3clinical trialsautoimmune diseases